期刊文献+

实体瘤外周血循环肿瘤细胞与转移相关性的研究进展 被引量:2

Relationship between circulating tumor cells in peripheral blood of solid tumor and metastasis
原文传递
导出
摘要 目的:总结实体瘤外周血中循环肿瘤细胞(CTC)和转移相关性的研究进展。方法:以"循环肿瘤细胞、实体瘤、转移"为关键词,检索2000-01-2010-10 PubMed、Science Direct、Ovid、Springer、CNKI和维普等数据库的相关文献。纳入标准:关于实体瘤CTC与转移密切相关的分子机制、临床相关性的文献。共纳入分析42篇文献。结果:随着分子生物学和材料技术的发展,越来越多的方法有效地富集和鉴定不同类型实体瘤外周血CTC。细胞基因水平证实CTC具有恶性生物学特性,CTC自身基因和转移相关蛋白谱的表达、肿瘤微环境、免疫系统等因素影响着CTC远处器官转移灶的形成。CTC数目、特定基因、蛋白的表达与治疗疗效、预后等具有相关性。结论:研究CTC参与血液播散转移的机制,为全面、准确地阐明恶性实体瘤转移的机制、个体化的治疗提供新的工具。 OBJECTIVE: To review of the studies the relation- ship between circulating tumor cells (CTC)in peripheral blood of solid tumors and the mechanism of metastasis. METHODS: Keyword: circulating tumor cell (CTC), solid tumors, metastasis. Retrieval system: PubMed, Ovid, Science Direct, Springer, CNKI, Weipu Data. The time limit: 2000-01--2010-10. The enrolled criteria: about the relationship between CTC in peripheral blood of solid tumors and :the mechanism of metastasis, its clinical rele- vance. Overall, 42 literatures were cited. RESULTS: As the development of the advanced technique of molecular biology and material, more and more methods can be used to enrich and identify CTC. It is reported that cytogenetic evidence that CTC in patients with carcinoma are malignant. The gene and related metastatic protein profile in CTC, tumor microenvironment, immune system can influence on tumor metastasis. The number of CTC, the expression of specific genes and proteins have a relationship with the effect of treatment and evaluation of prognosis. CONCLUSION: The study of the mechanism of CTC disseminating and metastasis to the organs may fully elucidate the mechanism of metastasis and be used as a new tool for tailored treatment for individual patient.
出处 《中华肿瘤防治杂志》 CAS 2011年第1期74-77,共4页 Chinese Journal of Cancer Prevention and Treatment
基金 江苏省卫生厅基金(H200970)
关键词 乳腺肿瘤 肿瘤循环细胞 肿瘤转移 综述文献 breast neoplasms neoplasms circulating cells neoplasm metastasis review literature
  • 相关文献

参考文献39

  • 1Husemann Y, Geigl J B, Schubert F, et al. Systemic spread is an earlystep in breast cancer[J]. Cancer Cell, 2008,13(1):58-68.
  • 2Ring A, Smith I E, Dowsett M. Circulating tumour cells inbreast caneer[J]. Laneet Oneol, 2004,5(2):79-88.
  • 3Deng G, Herrler M, Burgess D, et al. Enrichment with anti-cy-tokeratin alone or combined with anti-EpCAM antibodies signifi-cantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients[J]. Breast Cancer Res, 20O8,10(4) :R69.
  • 4Pinzani P, Salvadori B, Simi L, et al. Isolation by size of epithe- lial tumor cells in peripheral blood of patients with breast cancer:correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection[J]. Hum Pathol, 06,37(6) :711-718.
  • 5Nagrath S, Sequist L V, Maheswaran S, et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology[J]. Nature, 2007,450(7173) :1235-1239.
  • 6Mostert B, Kraan J, Bolt-de Vries J, et al. Detection of circu- lating tumor cells in breast cancer may improve through enrich- ment with anti-CD146[J]. Breast Cancer Res Treat,2010, Apr, 9[Epub ahead of printS.
  • 7Wu C, Hao H, Li L, et al. Preliminary investigation of the clin- ical significance of detecting circulating tumor cells enriched from lung cancer patients[J]. J Thorac Oncol,2009,4(1):30-36.
  • 8Ring A E, Zabaglo L, Ormerod M G, et al. Detection of circu-lating epithelial cells in the blood of patients with breast cancer:comparison of three techniques[J]. Br J Cancer, 2005,92(5)906-912.
  • 9Wu C H, Lin S R, Yu F J, et al. Development of a high-throughput membrane-array method for mOlecular diagnosis ofcirculating tumor cells in patients with gastric cancers[J]. Int JCancer, 2006,19(2):373-379.
  • 10Hu Y, Fan L, Zhang J, et al. Detoction of circulating tumorcells in breast cancer patients utilizing muhiparameter flow cytometry and assessment of the prognosis of patients in differentcjc,s levels[J]. Cytometry A, 2010,77A(3):213-219.

二级参考文献44

  • 1丁小文,郑树,丁小礼,韩明勇.乳腺癌患者外周血中组织特异性mRNA的表达及其临床意义[J].肿瘤防治杂志,2003,10(12):1254-1256. 被引量:2
  • 2刘剑仑,杨华伟,曹骥,杨南武.乳腺癌外周血微转移的检测及临床意义[J].中华肿瘤防治杂志,2006,13(16):1226-1228. 被引量:6
  • 3陈蕾,徐绮腻,郑瑾,林佩娟,张舜芬.乳腺癌临床特征与预后分析[J].中华肿瘤防治杂志,2007,14(15):1159-1162. 被引量:8
  • 4Pantel K, Brakenhoff R H, Brandt B. Detection, clinical relevance and specific biological properties of disseminating turnout cells[J]. Nat Rev Cancer, 2008,8(5) :329-340.
  • 5Hayes D F, Smerage J. Is there a role for circulating tumor cells in the management of breast cancer? [J]. Clin Cancer Res, 2008, 14 (12):3646-3650.
  • 6Riethdorf S, Pantel K. Disseminated tumor ceils in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization[J]. Pathobiology, 2008,75 (2) : 140-148.
  • 7Alix Panabieres C, Riethdorf S, Pantel K. Circulating tumor cells and bone marrow micrometastasis[J]. Clin Cancer Res, 2008, 14 (16): 5013-5021.
  • 8Husemann Y, Geigl J B, Schubert F, et al. Systemic spread is an early step in breast cancer[J]. Cancer Cell, 2008,13(1):58- 68.
  • 9Lang J E, Hall C S, Singh B. Significance of micrometastasis in bone marrow and blood of operable breast cancer patients: research tool or clinical application? [J]. Expert Rev Anticancer T her, 2007,7(10):1463-1472.
  • 10Pantel K, Brakenhoff R H. Dissecting the metastatic cascade[J]. Nat Rev Cancer, 2004, 4(6) : 448-456.

共引文献6

同被引文献24

  • 1李晶,姜北,万鹏,李娜,王于理,巩平.晚期非小细胞肺癌患者循环肿瘤细胞检测的临床意义[J].中国全科医学,2013,16(27):3202-3204. 被引量:15
  • 2褚佩英.肿瘤转移相关标志物——循环肿瘤细胞(CTC)[J].临床检验杂志(电子版),2014,3(3):675-677. 被引量:5
  • 3黄同海,王正,李富荣.循环肿瘤细胞检测的研究新进展[J].中国肿瘤临床,2007,34(8):476-479. 被引量:15
  • 4Goubran HA, Burnouf T, Radosevic M,et al. The platelet-cancer loopDJ. Eur J Intern Med,2013,24(5) ,393-400.
  • 5Takagi S, Sa to S, Oh-Hara T, et al. Platelets promote tumor growth and metastasis via direct interaction between aggrus/ po-doplanin and CLEC-2[J/CD]. PLoS One,2013 ,8(8) ,e73609.
  • 6Bazou D, Santos-Martinez MJ, Medina C, et al. Elucidation of flow-mediated tumour cell-induced platelet aggregation using an ultrasound standing wave trap [J]. Br J Pharmacol . 2011, 162(7),1577-1589.
  • 7Jurasz P, Sawicki G, Duszyk M, et al. Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide[J]. Cancer Res, 2001, 61(1) : 376-382.
  • 8Uluckan O, Eagleton MC, Floyd DH, et al. APT102, a novel adpase , cooperates with aspirin to disrupt bone metastasis in mice[J]. J Cell Biochem,2008,104(4) :1311-1323.
  • 9Trikha M, Zhou Z, Timar J, et al. Multiple roles for platelet GP II b/ ill a and alphavbeta3 integrins in tumor growth, angio-genesis, and metastasis[J]. Cancer Res, 2002, 62(10): 2824- 2833.
  • 10Amirkhosravi A, Mousa SA, Amaya M, et al. Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral Gpii b/illa antagonist XV454[J]. Thromb Haemost , 2003, 90(3) :549- 554.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部